These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7401912)

  • 21. Central injections of the GABA-transaminase inhibitor ethanolamine-O-sulfate (EOS): effects on brain [14C]2-deoxy-D-glucose uptake and behavior in rats.
    Nobrega JN; Coscina DV
    Brain Res; 1983 Mar; 262(2):243-52. PubMed ID: 6839155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced stimulant properties of (+)-amphetamine after chronic reserpine treatment in the rat: mediation by hypophagia and weight loss.
    Fibiger HC; Trimbach C; Campbell BA
    Neuropharmacology; 1972 Jan; 11(1):57-67. PubMed ID: 5060518
    [No Abstract]   [Full Text] [Related]  

  • 23. GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol.
    Kelly J; Rothstein J; Grossman SP
    Physiol Behav; 1979 Dec; 23(6):1123-34. PubMed ID: 542523
    [No Abstract]   [Full Text] [Related]  

  • 24. GABA and muscimol inhibit the release of prolactin from dispersed rat anterior pituitary cells.
    Grossman A; Delitala G; Yeo T; Besser GM
    Neuroendocrinology; 1981 Mar; 32(3):145-9. PubMed ID: 6261177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABAergic modulation of ethanol-induced motor impairment.
    Frye GD; Breese GR
    J Pharmacol Exp Ther; 1982 Dec; 223(3):750-6. PubMed ID: 6292399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    Biochem Pharmacol; 1980 Jun; 29(11):1451-4. PubMed ID: 7396979
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoamine involvement in the overeating caused by muscimol injection in the rat nucleus raphe dorsalis and the effects of d-fenfluramine and d-amphetamine.
    Borsini F; Bendotti C; Przewlocka B; Samanin R
    Eur J Pharmacol; 1983 Oct; 94(1-2):109-15. PubMed ID: 6653654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropharmacological spectrum of muscimol.
    Worms P; Depoortere H; Lloyd KG
    Life Sci; 1979 Aug; 25(7):607-14. PubMed ID: 574181
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of anorexic doses of dextro-amphetamine on the ventromedial-hypothalamic hyperphagic rat.
    Wishart TB; Walls EK
    Can J Physiol Pharmacol; 1973 May; 51(5):354-9. PubMed ID: 4583556
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of gamma-vinyl GABA on food intake of rats.
    Huot S; Palfreyman MG
    Pharmacol Biochem Behav; 1982 Jul; 17(1):99-106. PubMed ID: 7122673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of the GABA-transaminase inhibitor ethanolamine O-sulphate leads to up-regulation of GABA binding sites.
    Sykes C; Prestwich S; Horton R
    Biochem Pharmacol; 1984 Feb; 33(3):387-93. PubMed ID: 6322803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible inhibitory influence of gamma-aminobutyric acid on growth hormone secretion in the rat.
    Fiók J; Acs Z; Stark E
    J Endocrinol; 1981 Dec; 91(3):391-7. PubMed ID: 7328370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of benzodiazepines and barbiturates in a GABA-dependent animal model: interactions with muscimol in the globus pallidus [proceedings].
    Crossman AR; Lee LA; Longman DA; Slater P
    Br J Pharmacol; 1979 Jul; 66(3):493P-494P. PubMed ID: 43183
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationships between GABA and polyamines in developing rat brain.
    Seiler N; Bink G; Grove J
    Neuropharmacology; 1980 Mar; 19(3):251-8. PubMed ID: 7422079
    [No Abstract]   [Full Text] [Related]  

  • 36. A regional study of 4-aminobutyrate metabolism and amino acid levels in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    J Neurochem; 1982 Apr; 38(4):1022-8. PubMed ID: 7062027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of GABA in environmental temperature-induced change in body temperature.
    Biswas S; Poddar MK
    Methods Find Exp Clin Pharmacol; 1988 Dec; 10(12):747-9. PubMed ID: 3236943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cardiovascular responsiveness to GABAergic stimulation in DOCA-salt hypertensive rats.
    Magrì V; Trimarchi GR; Quattrone G; Squadrito F; Di Giorgio RM; Costa G; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):107-18. PubMed ID: 6433410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.
    Qume M; Whitton PS; Fowler LJ
    J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.